10-Q Filing
Filing Information
| Form Type | 10-Q |
| Accession Number | 0001551152-23-000023 |
| Period End Date | 20230331 |
| Filing Date | 20230505 |
| Fiscal Year | 2023 |
| Fiscal Period | Q1 |
| XBRL Instance | abbv-20230331_htm.xml |
Filing Contents
This filing contains the following financial statements:
Balance Sheet
68 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Common stock, par value (in dollars per share) |
CommonStockParOrStatedValuePerShare
|
$0.01 | USD | Point-in-time |
| Common stock, par value (in dollars per share) |
CommonStockParOrStatedValuePerShare
|
$0.01 | USD | Point-in-time |
| Common stock, authorized (in shares) |
CommonStockSharesAuthorized
|
4.00B | shares | Point-in-time |
| Common stock, authorized (in shares) |
CommonStockSharesAuthorized
|
4.00B | shares | Point-in-time |
| Common stock, issued (in shares) |
CommonStockSharesIssued
|
1.81B | shares | Point-in-time |
| Cash and equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$9.20B | USD | Point-in-time |
| Common stock, issued (in shares) |
CommonStockSharesIssued
|
1.82B | shares | Point-in-time |
| Cash and equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$6.71B | USD | Point-in-time |
| Treasury Stock, Common, Shares |
TreasuryStockCommonShares
|
57.11M | shares | Point-in-time |
| Treasury Stock, Common, Shares |
TreasuryStockCommonShares
|
44.59M | shares | Point-in-time |
| Short-term investments |
ShortTermInvestments
|
$11.00M | USD | Point-in-time |
| Short-term investments |
ShortTermInvestments
|
$28.00M | USD | Point-in-time |
| Accounts receivable, net |
AccountsReceivableNetCurrent
|
$11.47B | USD | Point-in-time |
| Accounts receivable, net |
AccountsReceivableNetCurrent
|
$11.25B | USD | Point-in-time |
| Inventories |
InventoryNet
|
$3.83B | USD | Point-in-time |
| Inventories |
InventoryNet
|
$3.58B | USD | Point-in-time |
| Prepaid expenses and other |
PrepaidExpenseAndOtherAssets
|
$4.40B | USD | Point-in-time |
| Prepaid expenses and other |
PrepaidExpenseAndOtherAssets
|
$4.46B | USD | Point-in-time |
| Total current assets |
AssetsCurrent
|
$28.46B | USD | Point-in-time |
| Total current assets |
AssetsCurrent
|
$26.49B | USD | Point-in-time |
| Investments |
LongTermInvestments
|
$241.00M | USD | Point-in-time |
| Investments |
LongTermInvestments
|
$257.00M | USD | Point-in-time |
| Property and equipment, net |
PropertyPlantAndEquipmentNet
|
$4.93B | USD | Point-in-time |
| Property and equipment, net |
PropertyPlantAndEquipmentNet
|
$4.93B | USD | Point-in-time |
| Intangible assets, net |
IntangibleAssetsNetExcludingGoodwill
|
$67.44B | USD | Point-in-time |
| Intangible assets, net |
IntangibleAssetsNetExcludingGoodwill
|
$64.85B | USD | Point-in-time |
| Goodwill |
Goodwill
|
$32.16B | USD | Point-in-time |
| Goodwill |
Goodwill
|
$32.22B | USD | Point-in-time |
| Other assets |
OtherAssetsNoncurrent
|
$5.57B | USD | Point-in-time |
| Other assets |
OtherAssetsNoncurrent
|
$5.80B | USD | Point-in-time |
| Total assets |
Assets
|
$138.81B | USD | Point-in-time |
| Total assets |
Assets
|
$134.54B | USD | Point-in-time |
| Short-term borrowings |
ShortTermBorrowings
|
$1.00M | USD | Point-in-time |
| Short-term borrowings |
ShortTermBorrowings
|
$1.00M | USD | Point-in-time |
| Current portion of long-term debt and finance lease obligations |
LongTermDebtAndCapitalLeaseObligationsCurrent
|
$2.80B | USD | Point-in-time |
| Current portion of long-term debt and finance lease obligations |
LongTermDebtAndCapitalLeaseObligationsCurrent
|
$4.13B | USD | Point-in-time |
| Accounts payable and accrued liabilities |
AccountsPayableAndAccruedLiabilitiesCurrent
|
$25.40B | USD | Point-in-time |
| Accounts payable and accrued liabilities |
AccountsPayableAndAccruedLiabilitiesCurrent
|
$24.79B | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$29.54B | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$27.59B | USD | Point-in-time |
| Long-term debt and finance lease obligations |
LongTermDebtAndCapitalLeaseObligations
|
$59.29B | USD | Point-in-time |
| Long-term debt and finance lease obligations |
LongTermDebtAndCapitalLeaseObligations
|
$59.13B | USD | Point-in-time |
| Deferred income taxes |
DeferredIncomeTaxLiabilitiesNet
|
$2.19B | USD | Point-in-time |
| Deferred income taxes |
DeferredIncomeTaxLiabilitiesNet
|
$2.11B | USD | Point-in-time |
| Other long-term liabilities |
OtherLiabilitiesNoncurrent
|
$30.66B | USD | Point-in-time |
| Other long-term liabilities |
OtherLiabilitiesNoncurrent
|
$32.25B | USD | Point-in-time |
| Commitments and contingencies |
CommitmentsAndContingencies
|
- | USD | Point-in-time |
| Commitments and contingencies |
CommitmentsAndContingencies
|
- | USD | Point-in-time |
| Common stock, $0.01 par value, 4,000,000,000 shares authorized, 1,821,082,016 shares issued as of March 31, 2023 and 1,813,770,294 as of December 31, 2022 |
CommonStockValueOutstanding
|
$18.00M | USD | Point-in-time |
| Common stock, $0.01 par value, 4,000,000,000 shares authorized, 1,821,082,016 shares issued as of March 31, 2023 and 1,813,770,294 as of December 31, 2022 |
CommonStockValueOutstanding
|
$18.00M | USD | Point-in-time |
| Common stock held in treasury, at cost, 57,113,024 shares as of March 31, 2023 and 44,589,000 as of December 31, 2022 |
TreasuryStockValue
|
$4.59B | USD | Point-in-time |
| Common stock held in treasury, at cost, 57,113,024 shares as of March 31, 2023 and 44,589,000 as of December 31, 2022 |
TreasuryStockValue
|
$6.52B | USD | Point-in-time |
| Additional paid-in capital |
AdditionalPaidInCapitalCommonStock
|
$19.25B | USD | Point-in-time |
| Additional paid-in capital |
AdditionalPaidInCapitalCommonStock
|
$19.62B | USD | Point-in-time |
| Retained earnings |
RetainedEarningsAccumulatedDeficit
|
$4.78B | USD | Point-in-time |
| Retained earnings |
RetainedEarningsAccumulatedDeficit
|
$2.39B | USD | Point-in-time |
| Accumulated other comprehensive loss |
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
$-2.23B | USD | Point-in-time |
| Accumulated other comprehensive loss |
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
$-2.20B | USD | Point-in-time |
| Total stockholders' equity |
StockholdersEquity
|
$13.27B | USD | Point-in-time |
| Total stockholders' equity |
StockholdersEquity
|
$17.25B | USD | Point-in-time |
| Noncontrolling interest |
MinorityInterest
|
$29.00M | USD | Point-in-time |
| Noncontrolling interest |
MinorityInterest
|
$33.00M | USD | Point-in-time |
| Total equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$17.29B | USD | Point-in-time |
| Total equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$13.30B | USD | Point-in-time |
| Total equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$15.44B | USD | Point-in-time |
| Total equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$16.31B | USD | Point-in-time |
| Total liabilities and equity |
LiabilitiesAndStockholdersEquity
|
$134.54B | USD | Point-in-time |
| Total liabilities and equity |
LiabilitiesAndStockholdersEquity
|
$138.81B | USD | Point-in-time |
Income Statement
40 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Net revenues |
Revenues
|
$12.22B | USD | 1 Quarter |
| Net revenues |
Revenues
|
$13.54B | USD | 1 Quarter |
| Cost of products sold |
CostOfGoodsAndServicesSold
|
$3.99B | USD | 1 Quarter |
| Cost of products sold |
CostOfGoodsAndServicesSold
|
$4.05B | USD | 1 Quarter |
| Selling, general and administrative |
SellingGeneralAndAdministrativeExpense
|
$3.04B | USD | 1 Quarter |
| Selling, general and administrative |
SellingGeneralAndAdministrativeExpense
|
$3.13B | USD | 1 Quarter |
| Research and development |
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
|
$2.29B | USD | 1 Quarter |
| Research and development |
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
|
$1.50B | USD | 1 Quarter |
| Acquired IPR&D and milestones |
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
|
$150.00M | USD | 1 Quarter |
| Acquired IPR&D and milestones |
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
|
$145.00M | USD | 1 Quarter |
| Other operating income |
OtherOperatingIncomeExpenseNet
|
- | USD | 1 Quarter |
| Other operating income |
OtherOperatingIncomeExpenseNet
|
$10.00M | USD | 1 Quarter |
| Total operating costs and expenses |
CostsAndExpenses
|
$9.46B | USD | 1 Quarter |
| Total operating costs and expenses |
CostsAndExpenses
|
$8.82B | USD | 1 Quarter |
| Operating earnings |
OperatingIncomeLoss
|
$2.77B | USD | 1 Quarter |
| Operating earnings |
OperatingIncomeLoss
|
$4.72B | USD | 1 Quarter |
| Interest expense, net |
InterestIncomeExpenseNonoperatingNet
|
$-454.00M | USD | 1 Quarter |
| Interest expense, net |
InterestIncomeExpenseNonoperatingNet
|
$-539.00M | USD | 1 Quarter |
| Net foreign exchange loss |
ForeignCurrencyTransactionGainLossBeforeTax
|
$-25.00M | USD | 1 Quarter |
| Net foreign exchange loss |
ForeignCurrencyTransactionGainLossBeforeTax
|
$-35.00M | USD | 1 Quarter |
| Other expense (income), net |
OtherNonoperatingIncomeExpense
|
$776.00M | USD | 1 Quarter |
| Other expense (income), net |
OtherNonoperatingIncomeExpense
|
$-1.80B | USD | 1 Quarter |
| Earnings before income tax expense |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
$475.00M | USD | 1 Quarter |
| Earnings before income tax expense |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
$4.93B | USD | 1 Quarter |
| Income tax expense |
IncomeTaxExpenseBenefit
|
$436.00M | USD | 1 Quarter |
| Income tax expense |
IncomeTaxExpenseBenefit
|
$234.00M | USD | 1 Quarter |
| Net earnings |
ProfitLoss
|
$241.00M | USD | 1 Quarter |
| Net earnings |
ProfitLoss
|
$4.49B | USD | 1 Quarter |
| Net earnings attributable to noncontrolling interest |
NetIncomeLossAttributableToNoncontrollingInterest
|
$3.00M | USD | 1 Quarter |
| Net earnings attributable to noncontrolling interest |
NetIncomeLossAttributableToNoncontrollingInterest
|
$2.00M | USD | 1 Quarter |
| Net earnings attributable to AbbVie Inc. |
NetIncomeLoss
|
$239.00M | USD | 1 Quarter |
| Net earnings attributable to AbbVie Inc. |
NetIncomeLoss
|
$4.49B | USD | 1 Quarter |
| Basic earnings per share (in dollars per share) |
EarningsPerShareBasic
|
$2.52 | USD | 1 Quarter |
| Basic earnings per share (in dollars per share) |
EarningsPerShareBasic
|
$0.13 | USD | 1 Quarter |
| Diluted earnings per share (in dollars per share) |
EarningsPerShareDiluted
|
$2.51 | USD | 1 Quarter |
| Diluted earnings per share (in dollars per share) |
EarningsPerShareDiluted
|
$0.13 | USD | 1 Quarter |
| Weighted-average basic shares outstanding (in shares) |
WeightedAverageNumberOfSharesOutstandingBasic
|
1.77B | shares | 1 Quarter |
| Weighted-average basic shares outstanding (in shares) |
WeightedAverageNumberOfSharesOutstandingBasic
|
1.77B | shares | 1 Quarter |
| Weighted-average diluted shares outstanding (in shares) |
WeightedAverageNumberOfDilutedSharesOutstanding
|
1.78B | shares | 1 Quarter |
| Weighted-average diluted shares outstanding (in shares) |
WeightedAverageNumberOfDilutedSharesOutstanding
|
1.78B | shares | 1 Quarter |
Cash Flow Statement
70 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Net earnings |
ProfitLoss
|
$241.00M | USD | 1 Quarter |
| Net earnings |
ProfitLoss
|
$4.49B | USD | 1 Quarter |
| Depreciation |
Depreciation
|
$179.00M | USD | 1 Quarter |
| Depreciation |
Depreciation
|
$198.00M | USD | 1 Quarter |
| Amortization of intangible assets |
AmortizationOfIntangibleAssets
|
$1.95B | USD | 1 Quarter |
| Amortization of intangible assets |
AmortizationOfIntangibleAssets
|
$1.85B | USD | 1 Quarter |
| Deferred income taxes |
DeferredIncomeTaxExpenseBenefit
|
$-194.00M | USD | 1 Quarter |
| Deferred income taxes |
DeferredIncomeTaxExpenseBenefit
|
$-267.00M | USD | 1 Quarter |
| Change in fair value of contingent consideration liabilities |
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
|
$-748.00M | USD | 1 Quarter |
| Change in fair value of contingent consideration liabilities |
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
|
$1.87B | USD | 1 Quarter |
| Stock-based compensation |
ShareBasedCompensation
|
$306.00M | USD | 1 Quarter |
| Stock-based compensation |
ShareBasedCompensation
|
$313.00M | USD | 1 Quarter |
| Acquired IPR&D and milestones |
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
|
$150.00M | USD | 1 Quarter |
| Acquired IPR&D and milestones |
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
|
$145.00M | USD | 1 Quarter |
| Impairment of intangible assets |
ImpairmentOfIntangibleAssetsExcludingGoodwill
|
$710.00M | USD | 1 Quarter |
| Impairment of intangible assets |
ImpairmentOfIntangibleAssetsExcludingGoodwill
|
- | USD | 1 Quarter |
| Other, net |
OtherNoncashIncomeExpense
|
$-128.00M | USD | 1 Quarter |
| Other, net |
OtherNoncashIncomeExpense
|
$128.00M | USD | 1 Quarter |
| Accounts receivable |
IncreaseDecreaseInAccountsReceivable
|
$785.00M | USD | 1 Quarter |
| Accounts receivable |
IncreaseDecreaseInAccountsReceivable
|
$195.00M | USD | 1 Quarter |
| Inventories |
IncreaseDecreaseInInventories
|
$385.00M | USD | 1 Quarter |
| Inventories |
IncreaseDecreaseInInventories
|
$185.00M | USD | 1 Quarter |
| Prepaid expenses and other assets |
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
$285.00M | USD | 1 Quarter |
| Prepaid expenses and other assets |
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
$167.00M | USD | 1 Quarter |
| Accounts payable and other liabilities |
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
$-465.00M | USD | 1 Quarter |
| Accounts payable and other liabilities |
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
$-258.00M | USD | 1 Quarter |
| Income tax assets and liabilities, net |
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
|
$438.00M | USD | 1 Quarter |
| Income tax assets and liabilities, net |
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
|
$187.00M | USD | 1 Quarter |
| Cash flows from operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$4.19B | USD | 1 Quarter |
| Cash flows from operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$4.91B | USD | 1 Quarter |
| Acquisitions and investments |
PaymentsToAcquireOtherInvestments
|
$353.00M | USD | 1 Quarter |
| Acquisitions and investments |
PaymentsToAcquireOtherInvestments
|
$185.00M | USD | 1 Quarter |
| Acquisitions of property and equipment |
PaymentsToAcquirePropertyPlantAndEquipment
|
$175.00M | USD | 1 Quarter |
| Acquisitions of property and equipment |
PaymentsToAcquirePropertyPlantAndEquipment
|
$162.00M | USD | 1 Quarter |
| Purchases of investment securities |
PaymentsToAcquireMarketableSecurities
|
$1.41B | USD | 1 Quarter |
| Purchases of investment securities |
PaymentsToAcquireMarketableSecurities
|
$19.00M | USD | 1 Quarter |
| Sales and maturities of investment securities |
ProceedsFromSaleMaturityAndCollectionsOfInvestments
|
$8.00M | USD | 1 Quarter |
| Sales and maturities of investment securities |
ProceedsFromSaleMaturityAndCollectionsOfInvestments
|
$22.00M | USD | 1 Quarter |
| Other, net |
PaymentsForProceedsFromOtherInvestingActivities
|
$-26.00M | USD | 1 Quarter |
| Other, net |
PaymentsForProceedsFromOtherInvestingActivities
|
$-154.00M | USD | 1 Quarter |
| Cash flows from investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$-1.59B | USD | 1 Quarter |
| Cash flows from investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$-499.00M | USD | 1 Quarter |
| Proceeds from issuance of long-term debt |
ProceedsFromIssuanceOfLongTermDebt
|
- | USD | 1 Quarter |
| Proceeds from issuance of long-term debt |
ProceedsFromIssuanceOfLongTermDebt
|
$2.00B | USD | 1 Quarter |
| Repayments of long-term debt and finance lease obligations |
RepaymentsOfLongTermDebtAndCapitalSecurities
|
$4.88B | USD | 1 Quarter |
| Repayments of long-term debt and finance lease obligations |
RepaymentsOfLongTermDebtAndCapitalSecurities
|
$1.35B | USD | 1 Quarter |
| Dividends paid |
PaymentsOfDividends
|
$2.53B | USD | 1 Quarter |
| Dividends paid |
PaymentsOfDividends
|
$2.66B | USD | 1 Quarter |
| Purchases of treasury stock |
PaymentsForRepurchaseOfCommonStock
|
$1.47B | USD | 1 Quarter |
| Purchases of treasury stock |
PaymentsForRepurchaseOfCommonStock
|
$1.96B | USD | 1 Quarter |
| Proceeds from the exercise of stock options |
ProceedsFromStockOptionsExercised
|
$65.00M | USD | 1 Quarter |
| Proceeds from the exercise of stock options |
ProceedsFromStockOptionsExercised
|
$128.00M | USD | 1 Quarter |
| Payments of contingent consideration liabilities |
PaymentForContingentConsiderationLiabilityFinancingActivities
|
$246.00M | USD | 1 Quarter |
| Payments of contingent consideration liabilities |
PaymentForContingentConsiderationLiabilityFinancingActivities
|
$311.00M | USD | 1 Quarter |
| Other, net |
ProceedsFromPaymentsForOtherFinancingActivities
|
$21.00M | USD | 1 Quarter |
| Other, net |
ProceedsFromPaymentsForOtherFinancingActivities
|
$21.00M | USD | 1 Quarter |
| Cash flows from financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$-6.19B | USD | 1 Quarter |
| Cash flows from financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$-6.97B | USD | 1 Quarter |
| Effect of exchange rate changes on cash and equivalents |
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$7.00M | USD | 1 Quarter |
| Effect of exchange rate changes on cash and equivalents |
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$8.00M | USD | 1 Quarter |
| Net change in cash and equivalents |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
$-2.49B | USD | 1 Quarter |
| Net change in cash and equivalents |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
$-3.65B | USD | 1 Quarter |
| Cash and equivalents, beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$6.71B | USD | Point-in-time |
| Cash and equivalents, beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$6.10B | USD | Point-in-time |
| Cash and equivalents, beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$9.75B | USD | Point-in-time |
| Cash and equivalents, beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$9.20B | USD | Point-in-time |
| Cash and equivalents, end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$6.71B | USD | Point-in-time |
| Cash and equivalents, end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$6.10B | USD | Point-in-time |
| Cash and equivalents, end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$9.75B | USD | Point-in-time |
| Cash and equivalents, end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$9.20B | USD | Point-in-time |
Stockholders Equity
20 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Beginning balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$17.29B | USD | Point-in-time |
| Beginning balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$13.30B | USD | Point-in-time |
| Beginning balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$15.44B | USD | Point-in-time |
| Beginning balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$16.31B | USD | Point-in-time |
| Net earnings attributable to AbbVie Inc. |
NetIncomeLoss
|
$239.00M | USD | 1 Quarter |
| Net earnings attributable to AbbVie Inc. |
NetIncomeLoss
|
$4.49B | USD | 1 Quarter |
| Other comprehensive income (loss), net of tax |
OtherComprehensiveIncomeLossNetOfTax
|
$-33.00M | USD | 1 Quarter |
| Other comprehensive income (loss), net of tax |
OtherComprehensiveIncomeLossNetOfTax
|
$-85.00M | USD | 1 Quarter |
| Dividends declared |
DividendsCommonStockCash
|
$2.63B | USD | 1 Quarter |
| Dividends declared |
DividendsCommonStockCash
|
$2.51B | USD | 1 Quarter |
| Purchases of treasury stock |
TreasuryStockValueAcquiredCostMethod
|
$1.47B | USD | 1 Quarter |
| Purchases of treasury stock |
TreasuryStockValueAcquiredCostMethod
|
$1.96B | USD | 1 Quarter |
| Stock-based compensation plans and other |
StockIssuedDuringPeriodValueShareBasedCompensation
|
$454.00M | USD | 1 Quarter |
| Stock-based compensation plans and other |
StockIssuedDuringPeriodValueShareBasedCompensation
|
$399.00M | USD | 1 Quarter |
| Change in noncontrolling interest |
MinorityInterestPeriodIncreaseDecrease
|
$-4.00M | USD | 1 Quarter |
| Change in noncontrolling interest |
MinorityInterestPeriodIncreaseDecrease
|
$3.00M | USD | 1 Quarter |
| Ending balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$17.29B | USD | Point-in-time |
| Ending balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$13.30B | USD | Point-in-time |
| Ending balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$15.44B | USD | Point-in-time |
| Ending balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$16.31B | USD | Point-in-time |
Comprehensive Income
26 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Net earnings |
ProfitLoss
|
$241.00M | USD | 1 Quarter |
| Net earnings |
ProfitLoss
|
$4.49B | USD | 1 Quarter |
| Foreign currency translation adjustments, net of tax expense (benefit) of $12 for the three months ended March 31, 2023 and $(7) for the three months ended March 31, 2022 |
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
|
$194.00M | USD | 1 Quarter |
| Foreign currency translation adjustments, net of tax expense (benefit) of $12 for the three months ended March 31, 2023 and $(7) for the three months ended March 31, 2022 |
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
|
$-231.00M | USD | 1 Quarter |
| Foreign currency translation adjustments, tax expense (benefit) |
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
|
$12.00M | USD | 1 Quarter |
| Foreign currency translation adjustments, tax expense (benefit) |
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
|
$-7.00M | USD | 1 Quarter |
| Net investment hedging activities, tax expense (benefit) |
OtherComprehensiveIncomeLossNetInvestmentHedgeTax
|
$37.00M | USD | 1 Quarter |
| Net investment hedging activities, tax expense (benefit) |
OtherComprehensiveIncomeLossNetInvestmentHedgeTax
|
$-60.00M | USD | 1 Quarter |
| Net investment hedging activities, net of tax expense (benefit) of $(60) for the three months ended March 31, 2023 and $37 for the three months ended March 31, 2022 |
OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossAfterReclassificationandTax
|
$130.00M | USD | 1 Quarter |
| Net investment hedging activities, net of tax expense (benefit) of $(60) for the three months ended March 31, 2023 and $37 for the three months ended March 31, 2022 |
OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossAfterReclassificationandTax
|
$-224.00M | USD | 1 Quarter |
| Pension and post-employment benefits, tax expense (benefit) |
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
|
$-14.00M | USD | 1 Quarter |
| Pension and post-employment benefits, tax expense (benefit) |
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
|
$-10.00M | USD | 1 Quarter |
| Pension and post-employment benefits, net of tax expense (benefit) of $14 for the three months ended March 31, 2023 and $10 for the three months ended March 31, 2022 |
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
|
$-28.00M | USD | 1 Quarter |
| Pension and post-employment benefits, net of tax expense (benefit) of $14 for the three months ended March 31, 2023 and $10 for the three months ended March 31, 2022 |
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
|
$-38.00M | USD | 1 Quarter |
| Cash flow hedging activities, tax expense (benefit) |
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
|
$-2.00M | USD | 1 Quarter |
| Cash flow hedging activities, net of tax expense (benefit) of $(4) for the three months ended March 31, 2023 and $(2) for the three months ended March 31, 2022 |
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
|
$-12.00M | USD | 1 Quarter |
| Cash flow hedging activities, tax expense (benefit) |
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
|
$-4.00M | USD | 1 Quarter |
| Cash flow hedging activities, net of tax expense (benefit) of $(4) for the three months ended March 31, 2023 and $(2) for the three months ended March 31, 2022 |
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
|
$-41.00M | USD | 1 Quarter |
| Other comprehensive loss |
OtherComprehensiveIncomeLossNetOfTax
|
$-33.00M | USD | 1 Quarter |
| Other comprehensive loss |
OtherComprehensiveIncomeLossNetOfTax
|
$-85.00M | USD | 1 Quarter |
| Comprehensive income |
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
$4.41B | USD | 1 Quarter |
| Comprehensive income |
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
$208.00M | USD | 1 Quarter |
| Comprehensive income attributable to noncontrolling interest |
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
|
$3.00M | USD | 1 Quarter |
| Comprehensive income attributable to noncontrolling interest |
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
|
$2.00M | USD | 1 Quarter |
| Comprehensive income attributable to AbbVie Inc. |
ComprehensiveIncomeNetOfTax
|
$4.41B | USD | 1 Quarter |
| Comprehensive income attributable to AbbVie Inc. |
ComprehensiveIncomeNetOfTax
|
$206.00M | USD | 1 Quarter |
Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.